10.31
Xeris Biopharma Holdings Inc (XERS) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
| 期間終了日 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues |
10.79%
92.10
|
83.13 | 85.81 | 74.38 | 71.54 |
|
|
14.85%
61.03
|
53.14 | - | - | - |
| Operating Income/Loss |
34.65%
5.173
|
7.916 | 16.77 | 6.731 | 4.482 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Net Income/Loss |
1,492%
-31.10
|
2.234 | 11.08 | 0.621 | -1.928 |
| Basic Average Shares |
1.35%
172.82
|
170.52 | 1.8657 | 163.65 | 159.46 |
| Diluted Average Shares |
2.71%
172.82
|
177.63 | 14.18 | 177.62 | 159.46 |
| Basic Earnings Per Share |
1,900%
-0.18
|
0.01 | 0.07 | - | -0.01 |
| Diluted Earnings Per Share |
1,900%
-0.18
|
0.01 | 0.07 | - | -0.01 |
大文字化:
|
ボリューム (24 時間):